NCT00668902View on ClinicalTrials.gov

Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Healthy
Interventions
DRUG

[13C]Pantoprazole

\[13C\]Pantoprazole was administered to EM, IM and PM of CYP2C19 and enzyme activity was measured through breath test and compared among the genotypes

Trial Locations (1)

46202

Indiana University, Indianapolis

All Listed Sponsors
collaborator

Sponsor Name Pending

INDUSTRY

lead

Indiana University

OTHER

NCT00668902 - Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole | Biotech Hunter | Biotech Hunter